Substance use amongst adolescents (those in the age group of 10-19) is an important public health issue in many countries of the region.
Prevention and early intervention
The monograph is an outcome of the Intergovernmental Committee on Drugs (IGCD) Fetal Alcohol Spectrum Disorder (FASD) Working Party.
Anxiety and alcohol use disorders are among the most prevalent and debilitating of mental health disorders, and commonly co-occur. This project aims to address crucial questions about when and how to intervene to prevent the onset and exacerbation of alcohol and anxiety comorbidity.
In recent years there has been growing attention on the use of crystal methamphetamine in Australia and the significant harms related to its use.
This Evidence Check forms a background document for the NSW Government public awareness strategy to reinforce the Government’s message that cannabis use is not supported.
Young people with comorbid disorders frequently come to the attention of a diverse range of service systems (e.g., health, social welfare, educational, and criminal justice systems), and present a significant challenge to service providers.
There has been a dramatic increase in opioid prescribing in Australia. This increase has been associated with increased harms including opioid dependence and overdose.
This research seeks to address the gap in early intervention research for cannabis use by developing and evaluating a school-based early intervention targeting young people suspended from school for a cannabis-related issue.
The current study will develop and pilot a personality-targeted mental health prevention program based on cognitive training tasks and delivered to adolescents at risk for developing a range of psychopathology.